T. van Staa

First name
T.
Middle name
P.
Last name
van Staa
Handoko, K. B., Souverein, P. C., van Staa, T. P., Meyboom, R. H., Leufkens, H. G., Egberts, T. C., & van den Bemt, P. M. (2006). Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia. http://doi.org/10.1111/j.1528-1167.2006.00596.x
View
van Staa, T. P., Card, T., Logan, R. F., & Leufkens, H. G. (2005). 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. Gut. http://doi.org/10.1136/gut.2005.070896
View
Edwards, C. J., Arden, N. K., Fisher, D., Saperia, J. C., Reading, I., van Staa, T. P., & Cooper, C. (2005). The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom General Practice Research Database. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kei024
View
Souverein, P. C., Webb, D. J., Petri, H., Weil, J., van Staa, T. P., & Egberts, T. (2005). Incidence of fractures among epilepsy patients: a population-based retrospective cohort study in the General Practice Research Database. Epilepsia. http://doi.org/10.1111/j.0013-9580.2005.23804.x
View
van Staa, T. P., Geusens, P., Bijlsma, J. W., Leufkens, H. G., & Cooper, C. (2006). Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. http://doi.org/10.1002/art.22117
View
de Vries, F., Souverein, P. C., Cooper, C., Leufkens, H. G., & van Staa, T. P. (2007). Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands. Calcif Tissue Int. http://doi.org/10.1007/s00223-006-0213-1
View
Wilting, I., de Vries, F., Thio, B. M., Cooper, C., Heerdink, E. R., Leufkens, H. G., et al. (2007). Lithium use and the risk of fractures. Bone. http://doi.org/10.1016/j.bone.2006.12.055
View
de Vries, F., Bracke, M., Leufkens, H. G., Lammers, J. W., Cooper, C., & van Staa, T. P. (2007). Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. http://doi.org/10.1002/art.22294
View
Edwards, C. J., Cooper, C., Fisher, D., Field, M., van Staa, T. P., & Arden, N. K. (2007). The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis. Arthritis Rheum. http://doi.org/10.1002/art.23003
View
van Staa, T. P., Geusens, P., Zhang, B., Leufkens, H. G., Boonen, A., & Cooper, C. (2007). Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/kel249
View